These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 28499958)

  • 1. Unexpected persistence of extended-spectrum β-lactamase-producing Enterobacteriaceae in the faecal microbiota of hospitalised patients treated with imipenem.
    Grall N; Lazarevic V; Gaïa N; Couffignal C; Laouénan C; Ilic-Habensus E; Wieder I; Plesiat P; Angebault C; Bougnoux ME; Armand-Lefevre L; Andremont A; Duval X; Schrenzel J
    Int J Antimicrob Agents; 2017 Jul; 50(1):81-87. PubMed ID: 28499958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of rates of fecal colonization with extended-spectrum beta-lactamase-producing enterobacteria among patients in different wards, outpatients and medical students.
    Ebrahimi F; Mózes J; Monostori J; Gorácz O; Fésűs A; Majoros L; Szarka K; Kardos G
    Microbiol Immunol; 2016 May; 60(5):285-94. PubMed ID: 26959958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Faecal carriage rate of extended-spectrum β-lactamase-producing Enterobacteriaceae in hospitalised patients and healthy asymptomatic individuals coming for health check-up.
    Babu R; Kumar A; Karim S; Warrier S; Nair SG; Singh SK; Biswas R
    J Glob Antimicrob Resist; 2016 Sep; 6():150-153. PubMed ID: 27530858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of Escherichia coli ST131 clonal complex (ST705) and Klebsiella pneumoniae ST15 among faecal carriage of extended-spectrum β-lactamase- and carbapenemase-producing Enterobacteriaceae.
    Ríos E; López MC; Rodríguez-Avial I; Culebras E; Picazo JJ
    J Med Microbiol; 2017 Feb; 66(2):169-174. PubMed ID: 27902381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut microbiome signatures of nursing home residents carrying Enterobacteria producing extended-spectrum β-lactamases.
    Le Bastard Q; Chapelet G; Birgand G; Hillmann BM; Javaudin F; Hayatgheib N; Bourigault C; Bemer P; De Decker L; Batard E; Lepelletier D; Montassier E
    Antimicrob Resist Infect Control; 2020 Jul; 9(1):107. PubMed ID: 32665016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colonization with extended-spectrum beta-lactamase-producing and carbapenemase-producing Enterobacteriaceae in international travelers returning to Germany.
    Lübbert C; Straube L; Stein C; Makarewicz O; Schubert S; Mössner J; Pletz MW; Rodloff AC
    Int J Med Microbiol; 2015 Jan; 305(1):148-56. PubMed ID: 25547265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High rate of faecal carriage of extended-spectrum β-lactamase and OXA-48 carbapenemase-producing Enterobacteriaceae at a university hospital in Morocco.
    Girlich D; Bouihat N; Poirel L; Benouda A; Nordmann P
    Clin Microbiol Infect; 2014 Apr; 20(4):350-4. PubMed ID: 23927757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of and risk factors associated with faecal carriage of CTX-M β-lactamase-producing Enterobacteriaceae in rural Thai communities.
    Luvsansharav UO; Hirai I; Nakata A; Imura K; Yamauchi K; Niki M; Komalamisra C; Kusolsuk T; Yamamoto Y
    J Antimicrob Chemother; 2012 Jul; 67(7):1769-74. PubMed ID: 22514260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High rate of faecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae in healthy children in Bangui, Central African Republic.
    Farra A; Frank T; Tondeur L; Bata P; Gody JC; Onambele M; Rafaï C; Vray M; Breurec S
    Clin Microbiol Infect; 2016 Oct; 22(10):891.e1-891.e4. PubMed ID: 27404368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology and risk factors for faecal extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBL-E) carriage derived from residents of seven nursing homes in western Shanghai, China.
    Zhao SY; Zhang J; Zhang YL; Wang YC; Xiao SZ; Gu FF; Guo XK; Ni YX; Han LZ
    Epidemiol Infect; 2016 Mar; 144(4):695-702. PubMed ID: 26260355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orally administered colistin leads to colistin-resistant intestinal flora and fails to prevent faecal colonisation with extended-spectrum β-lactamase-producing enterobacteria in hospitalised newborns.
    Strenger V; Gschliesser T; Grisold A; Zarfel G; Feierl G; Masoud L; Hoenigl M; Resch B; Müller W; Urlesberger B
    Int J Antimicrob Agents; 2011 Jan; 37(1):67-9. PubMed ID: 21074372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Faecal carriage of ESBL-producing Enterobacteriaceae and carbapenem-resistant Gram-negative bacilli in community settings.
    Villar HE; Baserni MN; Jugo MB
    J Infect Dev Ctries; 2013 Aug; 7(8):630-4. PubMed ID: 23949299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Faecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae is common 12 months after infection and is related to strain factors.
    Titelman E; Hasan CM; Iversen A; Nauclér P; Kais M; Kalin M; Giske CG
    Clin Microbiol Infect; 2014 Aug; 20(8):O508-15. PubMed ID: 24450760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Composition of the intestinal microbiota in extended-spectrum β-lactamase-producing Enterobacteriaceae carriers and non-carriers in Thailand.
    Piewngam P; Quiñones M; Thirakittiwatthana W; Yungyuen T; Otto M; Kiratisin P
    Int J Antimicrob Agents; 2019 Apr; 53(4):435-441. PubMed ID: 30578963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decolonization of intestinal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae with oral colistin and neomycin: a randomized, double-blind, placebo-controlled trial.
    Huttner B; Haustein T; Uçkay I; Renzi G; Stewardson A; Schaerrer D; Agostinho A; Andremont A; Schrenzel J; Pittet D; Harbarth S
    J Antimicrob Chemother; 2013 Oct; 68(10):2375-82. PubMed ID: 23719234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 5-day course of oral antibiotics followed by faecal transplantation to eradicate carriage of multidrug-resistant Enterobacteriaceae: a randomized clinical trial.
    Huttner BD; de Lastours V; Wassenberg M; Maharshak N; Mauris A; Galperine T; Zanichelli V; Kapel N; Bellanger A; Olearo F; Duval X; Armand-Lefevre L; Carmeli Y; Bonten M; Fantin B; Harbarth S;
    Clin Microbiol Infect; 2019 Jul; 25(7):830-838. PubMed ID: 30616014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High prevalence of faecal carriage of ESBL-producing Enterobacteriaceae in Norwegian patients with gastroenteritis.
    Jørgensen SB; Samuelsen O; Sundsfjord A; Bhatti SA; Jørgensen I; Sivapathasundaram T; Leegaard TM
    Scand J Infect Dis; 2014 Jun; 46(6):462-5. PubMed ID: 24702690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fecal carriage of extended-spectrum and AmpC β-lactamase-producing Enterobacteriaceae in surgical patients before and after antibiotic prophylaxis.
    Jakobsen L; Kuhn KG; Hansen F; Skov RL; Hammerum AM; Littauer PJ; Thorlacius-Ussing O; Gebuhr PH; Knudsen JD; Schønheyder HC
    Diagn Microbiol Infect Dis; 2016 Nov; 86(3):316-321. PubMed ID: 27567284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors associated with preoperative fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae in liver transplant recipients.
    Bert F; Larroque B; Dondero F; Durand F; Paugam-Burtz C; Belghiti J; Moreau R; Nicolas-Chanoine MH
    Transpl Infect Dis; 2014 Feb; 16(1):84-9. PubMed ID: 24330161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High Prevalence of Faecal Carriage of ESBL-Producing Enterobacteriaceae among Children in Dar es Salaam, Tanzania.
    Tellevik MG; Blomberg B; Kommedal Ø; Maselle SY; Langeland N; Moyo SJ
    PLoS One; 2016; 11(12):e0168024. PubMed ID: 27936054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.